LobbyingAmity Holdings LLC Dba Pip Diabetes Care lobbying by quarter
Amity Holdings LLC Dba Pip Diabetes Care's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q3 2024; the issues it reports most are Medical/Disease Research/Clinical Labs.
Amity Holdings LLC Dba Pip Diabetes Care
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$20K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES8 reports
- SENATE8 reports
Firms it paid
| Firm | ||
|---|---|---|
| Wise Capital Strategy | $20K | 8 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Wise Capital Strategy | Under $5,000 |
| 04/14for Q1 | Wise Capital Strategy | Under $5,000 |
| 01/19for Q4 2025 | Wise Capital Strategy | Under $5,000 |
| 25/10/18for Q3 2025 | Wise Capital Strategy | Under $5,000 |
| 25/07/18for Q2 2025 | Wise Capital Strategy | Under $5,000 |
| 25/04/17for Q1 2025 | Wise Capital Strategy | Under $5,000 |
| 25/01/14for Q4 2024 | Wise Capital Strategy | $10K |
| 24/10/19for Q3 2024 | Wise Capital Strategy | $10K |
| 24/08/13for Q3 2024 | Wise Capital Strategy | Under $5,000 |